Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Abstract In sub-Saharan Africa, simple biomarkers of liver fibrosis are needed to scale-up
hepatitis B treatment. We conducted an individual participant data meta-analysis of 3,548 …

Background & Aims More than 292 million people are living with hepatitis B worldwide and
are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) …

Summary Background Hepatitis B virus (HBV) elimination requires expanding and
decentralising HBV care services. However, peripheral health facilities lack access to …

Study concept and design, YS, YT; acquisition of data, YS, GN, AC, AK, AH, NY, KA, ML;
analysis and interpretation of data, YS, TC, AK, KA, JPV, ML, YT; drafting of the manuscript …

Background International Sustainable Development Goals (SDGs) for elimination of
hepatitis B virus (HBV) infection set ambitious targets for 2030. In African populations, infant …

Despite the heavy disease burden posed by hepatitis B, around 90% of people living with
hepatitis B are not diagnosed globally. Many of the affected populations still have limited or …

Hepatocellular carcinoma is a leading public health concern in sub-Saharan Africa, and it is
most prevalent in young adults (median 45 years [IQR 35–57]). Overall, outcomes are poor …

More than 2 billion people have been exposed to the hepatitis B virus (HBV) of whom an
estimated 257 million people have chronic infection. 1 Chronic HBV infection occurs globally …